Brain Screenings Offered to Breast Cancer Patients During Breast Cancer Aware...( Neurologic and Orthopedic Institute...),Health

Neurologic and Orthopedic Institute of Chicago Offer Complimentary Brain

Scans, Oct 26 & 27, as Part of Clinical Study.

CHICAGO, Oct. 19 /PRNewswire/ --

What: Women diagnosed with HER-2 positive Stage III or Stage IV

breast cancer are eligible to receive an MRI of the brain

at no charge as part of a clinical trial. HER2 is a breast

cancer that tests positive for a protein called human

epidermal growth factor receptor-2 (HER2), which promotes

the growth of cancer cells. Studies have shown that in as

many as 30 percent of breast cancer patients have a

metastasis in the brain. As part of the screening

protocol, participants will undergo a MRI of the brain. The

cost of the MRI is covered by the clinical trial.

Who: Patients who qualify must have an initial primary diagnosis

of high risk and/or HER-2 positive breast cancer. They

must be at least 18 years and should not participate if

they are pregnant.

When: Friday, October 26th, 1 p.m. to 9 p.m.

Saturday, October 27th, 8 a.m. to 5 p.m.

Where: Neurologic and Orthopedic Institute of Chicago

4501 N. Winchester, Chicago

Cost: The brain MRI is free of charge to the patient.

Background: The Chicago Institute of Neurosurgery and Neuroresearch

(CINN) Medical Group will use information from the

screening to determine the potentialbenefit(s) of screening

for brain metastases in patients with advanced breast

cancer.

Study Selection & Enrollment Criteria

Women must be within three to twenty-four m
'/>"/>